Structure-Based Drug Design (eBook, PDF)
Redaktion: Marti, Marcelo A.; Fernández Do Porto, Dario; Turjanski, Adrian Gustavo
105,95 €
105,95 €
inkl. MwSt.
Sofort per Download lieferbar
53 °P sammeln
105,95 €
Als Download kaufen
105,95 €
inkl. MwSt.
Sofort per Download lieferbar
53 °P sammeln
Jetzt verschenken
Alle Infos zum eBook verschenken
105,95 €
inkl. MwSt.
Sofort per Download lieferbar
Alle Infos zum eBook verschenken
53 °P sammeln
Structure-Based Drug Design (eBook, PDF)
Redaktion: Marti, Marcelo A.; Fernández Do Porto, Dario; Turjanski, Adrian Gustavo
- Format: PDF
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei
bücher.de, um das eBook-Abo tolino select nutzen zu können.
Hier können Sie sich einloggen
Hier können Sie sich einloggen
Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
This volume focuses on target-oriented approximations to drug discovery, including target selection, binding pocket detection, and current uses and variants of molecular dynamics and molecular docking. The primary audience is PhD and graduates working in the field of molecular biology, structural biology, pharmaceutical sciences.
- Geräte: PC
- ohne Kopierschutz
- eBook Hilfe
- Größe: 13.44MB
Andere Kunden interessierten sich auch für
- Biomedical Translational Research (eBook, PDF)161,95 €
- Ashutosh Kumar ShuklaESR Spectroscopy for Life Science Applications: An Introduction (eBook, PDF)40,95 €
- Carbonic Anhydrase as Drug Target (eBook, PDF)73,95 €
- Mukesh MaithaniDevelopment of Novel Stability Indicating Methods Using Liquid Chromatography (eBook, PDF)73,95 €
- Controlled Pulmonary Drug Delivery (eBook, PDF)161,95 €
- Translational Research and Onco-Omics Applications in the Era of Cancer Personal Genomics (eBook, PDF)73,95 €
- HSP70 in Human Diseases and Disorders (eBook, PDF)73,95 €
-
-
-
This volume focuses on target-oriented approximations to drug discovery, including target selection, binding pocket detection, and current uses and variants of molecular dynamics and molecular docking. The primary audience is PhD and graduates working in the field of molecular biology, structural biology, pharmaceutical sciences.
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Springer Nature Switzerland
- Seitenzahl: 256
- Erscheinungstermin: 15. Oktober 2024
- Englisch
- ISBN-13: 9783031691621
- Artikelnr.: 71916037
- Verlag: Springer Nature Switzerland
- Seitenzahl: 256
- Erscheinungstermin: 15. Oktober 2024
- Englisch
- ISBN-13: 9783031691621
- Artikelnr.: 71916037
- Herstellerkennzeichnung Die Herstellerinformationen sind derzeit nicht verfügbar.
Prof. Marcelo Marti holds a Ms.S. in Molecular Biology and a PhD in Theoretical Chemistry and Biophysics, both at the University of Buenos Aires. He is a Full Professor at the Department of Biological Chemistry (Universidad de Buenos Aires) and a Principal Researcher at the Argentinean Council of Science. His research interests lie in understanding the molecular basis of protein functions and genomics using bioinformatic tools. He has published over 100 articles in top ranked international journals in the field including over 3000 citations (h index = 33). Prof. Turjanski is a Full Professor in Bioinformatics at the University of Buenos Aires and a Principal Researcher at the Argentinean Council of Science. He obtained his PhD in Chemistry at the University of Buenos Aires and obtained a PhD position at the Fogarty Center at NIH, 2005-2008. He has been the head of the National Center for Interdisciplinary Science, at the Ministry of Sciences and Technology, Facultad de Ciencias Exactas y Naturales from 2015-2019, and the head of the Binational Center of Bioinformatics (Argentina/Spain). He was a member of the Argentinian Committee at the European Molecular Biology Lab and the head of the Argentinian Bioinformatics Platform since 2012. He has published over 100 indexed articles, with a h-index of 25. Dr. Fernandez Do Porto holds a degree in Biology and a PhD in Biological Chemistry, both from the University of Buenos Aires. His research interests focus on pathogen genomics, integrating omics data, and structural and functional bioinformatics for drug discovery. He is an Independent researcher at the Argentinean Council of Science and a Full Professor in the Biological Chemistry department, Exact and Natural Sciences School, Buenos Aires University. He has published over 40 indexed articles.
Prioritizing Drug Targets in Pathogenic Bacteria by Harnessing Structural Biology, Metabolic Analysis, and Omics Data Integration.- Regulatory small RNAs as antimicrobial drug targets.- Riboswitches as antimicrobial targets.- Pre-selection of compounds for lead identification in virtual screening campaigns.- Docking and Bias Docking.- Molecular Dynamics and its Significance in Drug Discovery.- Deep Learning Strategies for Enhanced Molecular Docking and Virtual Screening.- Integrating computational approaches from non-synonymous sequence variations to molecular structure for drug repositioning targeting the SARS-CoV-2 Spike protein.
Prioritizing Drug Targets in Pathogenic Bacteria by Harnessing Structural Biology, Metabolic Analysis, and Omics Data Integration.- Regulatory small RNAs as antimicrobial drug targets.- Riboswitches as antimicrobial targets.- Pre-selection of compounds for lead identification in virtual screening campaigns.- Docking and Bias Docking.- Molecular Dynamics and its Significance in Drug Discovery.- Deep Learning Strategies for Enhanced Molecular Docking and Virtual Screening.- Integrating computational approaches from non-synonymous sequence variations to molecular structure for drug repositioning targeting the SARS-CoV-2 Spike protein.